Fraunhofer Institute for Interfacial Engineering and Bioprocess Engineering

from Wikipedia, the free encyclopedia
Fraunhofer Institute for
Interfacial Engineering and Biotechnology IGB
Category: research Institute
Carrier: Fraunhofer Society
Legal form of the carrier: Registered association
Seat of the wearer: Munich
Facility location: Stuttgart
Branch offices: BioCat branch in Straubing , Fraunhofer CBP in Leuna
Type of research: Applied research
Subjects: Engineering , natural sciences , life sciences
Areas of expertise: Biology , biotechnology , life sciences , chemistry , physics , process engineering , materials science , interfacial process engineering
Basic funding: Federal government (90%), states (10%)
Management: Markus Wolperdinger
Employee: about 340
Homepage: www.igb.fraunhofer.de

The Fraunhofer Institute for Interfacial Engineering and Bioprocess Engineering IGB , called "Fraunhofer IGB" for short, is an institution of the Fraunhofer Society . The institute is based in Stuttgart and has parts of the institute in Leuna and Straubing . Its activities can be assigned to applied research and development in the fields of engineering and natural sciences .

history

In 1953 it was founded in Kirchheimbolanden (Palatinate) as a private "Institute for Physics and Chemistry of Interfaces". In 1962, the Fraunhofer-Gesellschaft took over the facility as the Fraunhofer Institute for the Physics and Chemistry of Interfaces IGf, and in 1969 it moved to the university in Stuttgart. In 1976 the institute was given its current name as a result of the thematic expansion to include bioprocess engineering . From 1976 to 1992 Horst Chmiel was director of the Fraunhofer Institute (IGB) and from 1986 to 1992 professor for bioprocess engineering at the University of Stuttgart .

From May 1994 to December 2007, Herwig Brunner was director of the Fraunhofer Institute (IGB) and the newly founded Institute for Interfacial Process Engineering (IGVT) at the University of Stuttgart . He developed the Fraunhofer IGB into one of the first life sciences institutes of the Fraunhofer Society by expanding competencies in molecular biotechnology and tissue engineering and linking them with interdisciplinary process engineering.

From December 2007 to December 2015 Thomas Hirth was head of the Fraunhofer Institute (IGB) and the Institute for Interfacial Process Engineering and Plasma Technology (IGVP) at the University of Stuttgart . With the Fraunhofer Center for Chemical-Biotechnological Processes CBP in Leuna, which was inaugurated by Chancellor Angela Merkel on October 2, 2012, he created a facility to transfer the material use of renewable raw materials more quickly into industrial applications and to German and European applications Strengthen bioeconomy research.

With Hirth's change to the presidium of the Karlsruhe Institute of Technology KIT in 2016, Katja Schenke-Layland and Christian Oehr took over the provisional management of the institute.

Markus Wolperdinger has been Head of Fraunhofer IGB since March 2018.

Institute parts

Fraunhofer Center for Chemical-Biotechnological Processes CBP, Leuna

By providing infrastructure and pilot plant / mini-plant systems, the Fraunhofer Center for Chemical-Biotechnological Processes CBP enables cooperation partners from research and industry to develop and scale biotechnological and chemical processes for the use of renewable raw materials up to an industrial scale. The main focus is on the digestion of lignocellulose and the recycling of biogenic substrates as well as the development of technical enzymes.

Bio-, electro- and chemocatalysis BioCat, Straubing branch

The BioCat branch of the institute focuses on the development of new bio and chemical catalysts and their application. Starting with substrates such as biomass, CO 2 , organic and inorganic residues or waste streams, the entire spectrum of catalysis is used to produce new chemical products in a sustainable and resource-saving manner. In addition, BioCat is developing processes to use excess electrical energy by binding and converting CO 2 into chemical energy storage .

Research and Development

The institute deals with issues in the fields of cell biology, microbiology, biotechnology and bioprocess engineering as well as chemical, physical and interfacial process engineering. On this basis - and in particular through the combination of biological and process engineering or materials science competencies - the institute develops and optimizes processes, technologies and products for the business fields of health, sustainable chemistry and the environment. In addition to contract research, the institute also carries out accredited analyzes and tests.

Technologies

Cell and tissue technologies

Human, physiological in vitro test models for the non-clinical testing of drugs and the determination of the toxicity and allergenicity of materials.

In vitro diagnostics

Establishment, development and utilization of diagnostic procedures for biological and medical applications using DNA high-throughput sequencing (Next-Generation Sequencing, NGS).

Virus-based technologies

Concepts and solutions for the use of viruses and phages for targeted prevention, therapy, diagnostics in medicine and bio-intelligent use in biotechnology.

Functional ingredients

Tailor-made production and processing of functional ingredients from microalgae, bacteria and residues for the production of food and feed, cosmetics and bio-based materials.

Water technologies and resource recovery

Concepts, processes and technologies for water purification and recovery of valuable substances from water. The focus is on integrated energy, waste and water management , nutrient recovery and the efficient production of biogas.

See also : process engineering , electrochemistry , wastewater treatment , advanced oxidation processes

Membranes

Development of hollow fiber and flat membranes via phase inversion processes from laboratory to pilot scale.

Functional surfaces and materials

Development and characterization of functional surfaces and materials through coatings from gas and liquid phase, formulations and process development from laboratory to roll-to-roll pilot scale.

Renewable resources

Processes for the material use of regenerative resources for the production of chemicals - value chains from laboratory to pilot plant scale.

Industrial biotechnology

Development of biotechnological processes for the production of bio-based fine and platform chemicals for further processing for the chemical industry and cosmetics, cleaning agents, plastics or adhesives.

Catalysts

Development of chemical, electrochemical and biotechnological catalysts for the sustainable production of chemicals and fuels from renewable resources.

Bio-inspired chemistry

Development of sustainable synthesis and production methods for bio-based fine and specialty chemicals as well as materials for high-tech applications by combining biology and chemistry.

Business areas

health

With fast and accurate molecular diagnostics as well as individualized therapeutic approaches, new test systems for pre- and non-clinical drug development, with new coatings, formulations and release systems, the Fraunhofer IGB is aimed at companies from diagnostics and laboratory analysis, the pharmaceutical industry and medical technology.

Sustainable chemistry

The dependence on the import of raw materials, the limitation of fossil resources worldwide and the need to take into account the effects on the climate and the environment, the work of the institute focuses on approaches to better use or substitute fossil resources. The portfolio therefore includes on the one hand functional surfaces and materials, on the other hand the development and conversion of regenerative raw materials with fermentation and biocatalysis, bio-based chemicals as their products and biorefinery concepts for the fullest possible use of raw materials. Process of (electro) chemical conversion, u. a. of CO 2 and corresponding processing technologies round off the portfolio.

environment

Against the background of climate change, resource scarcity and water pollution, the Fraunhofer IGB pursues the goal of using new technologies to enable resource and environmentally friendly economic activity. In addition, it deals with sustainable water and wastewater technology, water monitoring, the processing of raw and residual materials, the energetic use of residual biomass and the development of membranes for the energy transition.

Connection to universities

In its basic research , the Fraunhofer IGB is mainly supported by the Institute for Interfacial Process Engineering and Plasma Technology IGVP at the University of Stuttgart . Further collaborations in the university sector exist with the University of Tübingen and the Technical University of Munich .

Cooperations

The institute is a member of the Fraunhofer Group for Life Sciences and a host institute in the Fraunhofer Group for Materials and Components - MATERIALS. In addition, the institute is active in numerous Fraunhofer alliances. The Fraunhofer institutes bundle their respective competencies in this in order to work on and market a business area together.

Infrastructure

The institute has laboratories and technical centers up to biological safety level S2. Certain test laboratories and test methods in analysis have been accredited according to the DIN EN ISO / IEC 17025 standard. In addition, the institute has a GLP test facility for test category 9: Cell-based test systems for determining biological parameters.

The institute provides modular process capacities for dealing with procedural issues and continuous systems as well as various processing and processing techniques for use by industrial partners.

In addition, the institute has analysis methods from specialist areas, such as scanning electron microscopy , atomic force microscopy or X-ray photoelectron spectroscopy in surface analysis .

Financing and Human Resources

The operating budget is financed by external income and institutional funding (basic funding). In the 2019 financial year, the operating budget was 25.2 million euros. 70 percent of the operating budget comes from own income; 33 percent of the company's own income from contract research.

At the end of 2019, the institute had around 340 employees, over 90 percent of them in the scientific and technical areas. The proportion of women was 53 percent.

Web links

Individual evidence

  1. ↑ https://www.igb.fraunhofer.de/de/ueber-uns/institutsprofil/institutsleitung.html
  2. ↑ history. Fraunhofer IGB, accessed April 25, 2017 .
  3. ↑ Annual report 2012/13 - 60 years of Fraunhofer IGB. (PDF; 4.0 MB) Fraunhofer IGB, accessed on April 25, 2017 .
  4. ↑ Federal Chancellor visits Fraunhofer CBP in the top cluster BioEconomy. In: press release. Fraunhofer IGB, accessed April 25, 2017 .
  5. ↑ Katja Schenke-Layland and Christian Oehr take over the management of the Fraunhofer IGB. In: press release. Fraunhofer IGB, accessed April 25, 2017 .
  6. ↑ Markus Wolperdinger takes over the management of the Fraunhofer IGB. In: press release. Fraunhofer IGB, accessed on May 28, 2020 .
  7. ↑ Analysis and testing services. Fraunhofer IGB, accessed on May 28, 2020 .
  8. ↑ Business areas. Fraunhofer IGB, accessed on May 28, 2020 .
  9. ↑ fields of innovation. Fraunhofer IGB, accessed on May 28, 2020 .
  10. ↑ teaching. Fraunhofer IGB, accessed on May 28, 2020 .
  11. ↑ Network. Fraunhofer IGB, accessed on May 28, 2020 .
  12. ↑ Infrastructure and quality systems. Fraunhofer IGB, accessed April 25, 2017 .
  13. ↑ Fraunhofer Center for Chemical-Biotechnological Processes CBP equipment. Fraunhofer IGB, accessed on May 28, 2020 .
  14. ↑ Annual report 2019/20. (PDF; 2.4 MB) Fraunhofer IGB, accessed on May 28, 2020 .

Coordinates: 48 ° 44 '30.1 "  N , 9 ° 5' 58.2"  E